Morimoto K - Search Results

1

[Co-operative clinical evaluation of 5'-DFUR tablets for breast cancer at 31 institutions].

Morimoto K, Taguchi T, Ohta J, Miura S, Ueda N, Yayoi K, Inaji H. Morimoto K, et al. Gan To Kagaku Ryoho. 1992 Jul;19(7):1041-8. Gan To Kagaku Ryoho. 1992. PMID: 1385688 Clinical Trial. Japanese.

2

[A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].

Saeki T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Taguchi T. Saeki T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 2004 Apr;31(4):539-47. Gan To Kagaku Ryoho. 2004. PMID: 15114697 Clinical Trial. Japanese.

3

[An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].

Taguchi T, Morimoto K, Horikoshi N, Takashima S, Toge T, Kimura M, Sano M, Aoyama H, Ota J, Noguchi S. Taguchi T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1998 Jun;25(7):1035-43. Gan To Kagaku Ryoho. 1998. PMID: 9644319 Clinical Trial. Japanese.

4

[A dose-comparative study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group].

Taguchi T, Koyama H, Yayoi K, Wada T, Takatsuka Y, Sonoo H, Morimoto K, Tominaga T, Abe R, Enomoto K, et al. Taguchi T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1995 Mar;22(4):477-94. Gan To Kagaku Ryoho. 1995. PMID: 7887640 Clinical Trial. Japanese.

5

[Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group].

Taguchi T, Koyama H, Yayoi K, Wada T, Takatsuka Y, Sonoo H, Morimoto K, Tominaga T, Abe R, Enomoto K, et al. Taguchi T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1995 Mar;22(4):495-508. Gan To Kagaku Ryoho. 1995. PMID: 7887641 Clinical Trial. Japanese.

6

[A late phase II study of CPT-11 (irinotecan) in advanced breast cancer. CPT-11 Study Group on Breast Cancer].

Taguchi T, Tominaga T, Ogawa M, Ishida T, Morimoto K, Ogawa N. Taguchi T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1994 Jun;21(7):1017-24. Gan To Kagaku Ryoho. 1994. PMID: 8210251 Clinical Trial. Japanese.

7

[LY188011 phase I study. Research Group of Gemcitabine (LY188011)].

Taguchi T, Furuse K, Fukuoka M, Shimoyama T, Morimoto K, Nakamura T, Furue H, Majima H, Niitani H, Ohta K, Wakui A, Nakao I, Tsukagoshi S. Taguchi T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1996 Jul;23(8):1011-8. Gan To Kagaku Ryoho. 1996. PMID: 8687215 Clinical Trial. Japanese.

8

A phase II study of S-1 in patients with metastatic breast cancer--a Japanese trial by the S-1 Cooperative Study Group, Breast Cancer Working Group.

Saek T, Takashima S, Sano M, Horikoshi N, Miura S, Shimizu S, Morimoto K, Kimura M, Aoyama H, Ota J, Noguchi S, Taguchi T. Saek T, et al. Among authors: morimoto k. Breast Cancer. 2004;11(2):194-202. doi: 10.1007/BF02968301. Breast Cancer. 2004. PMID: 15550867 Clinical Trial.

9

[Therapeutic results in recurrent breast cancer with the use of Bestrabucil (KM2210)].

Ueda T, Sakai K, Morimoto K, Nakatani S. Ueda T, et al. Among authors: morimoto k. Gan To Kagaku Ryoho. 1987 Dec;14(12):3285-9. Gan To Kagaku Ryoho. 1987. PMID: 3688892 Japanese.

10

[Steady state and disappearance of the metabolites of miproxifene phosphate in the treatment of breast cancer].

Morimoto K, Abe O, Kinoshita H. Morimoto K, et al. Gan To Kagaku Ryoho. 1998 Aug;25(10):1565-73. Gan To Kagaku Ryoho. 1998. PMID: 9725050 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,267 results

Search Page

Filters